Different phylogenomic methods support monophyly of enigmatic 'Mesozoa' (Dicyemida + Orthonectida, Lophotrochozoa).
Marie DrábkováKevin M KocotKenneth M HalanychTodd H OakleyLeonid L MorozJohanna T CannonArmand KurisAna Elisa Garcia-VedrenneM Sabrina PankeyEmily A EllisRebecca VarneyJan ŠtefkaJan ZrzavýPublished in: Proceedings. Biological sciences (2022)
Dicyemids and orthonectids were traditionally classified in a group called Mesozoa, but their placement in a single clade has been contested and their position(s) within Metazoa is uncertain. Here, we assembled a comprehensive matrix of Lophotrochozoa (Metazoa) and investigated the position of Dicyemida (= Rhombozoa) and Orthonectida, employing multiple phylogenomic approaches. We sequenced seven new transcriptomes and one draft genome from dicyemids ( Dicyema , Dicyemennea ) and two transcriptomes from orthonectids ( Rhopalura ). Using these and published data, we assembled and analysed contamination-filtered datasets with up to 987 genes. Our results recover Mesozoa monophyletic and as a close relative of Platyhelminthes or Gnathifera. Because of the tendency of the long-branch mesozoans to group with other long-branch taxa in our analyses, we explored the impact of approaches purported to help alleviate long-branch attraction (e.g. taxon removal, coalescent inference, gene targeting). None of these were able to break the association of Orthonectida with Dicyemida in the maximum-likelihood trees. Contrastingly, the Bayesian analysis and site-specific frequency model in maximum-likelihood did not recover a monophyletic Mesozoa (but only when using a specific 50 gene matrix). The classic hypothesis on monophyletic Mesozoa is possibly reborn and should be further tested.
Keyphrases
- genome wide
- single cell
- genome wide identification
- copy number
- rna seq
- dna methylation
- risk assessment
- genome wide analysis
- randomized controlled trial
- magnetic resonance imaging
- cancer therapy
- mass spectrometry
- big data
- systematic review
- magnetic resonance
- drug delivery
- computed tomography
- high resolution
- heavy metals
- artificial intelligence
- deep learning
- single molecule